BC Platforms, a provider of genomic data management and analytics, has completed a $15 million financing round along with a new commercial collaboration with IQVIA. The round was led by IQVIA in conjunction with Debiopharm Innovation Fund and Tesi, a Finnish venture capital and private equity company. As part of the collaboration, IQVIA and BC Platforms plan to launch new data driven technologies, integrating complex clinical and genomic data, to benefit transformational research. IQVIA and B...